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ABSTRACT
Introduction: The aim of this study was to
assess distance, intermediate, and near visual
acuity, contrast sensitivity, and patient
satisfaction outcomes of a multifocal
intraocular lens (IOL).
Methods: This multicenter, prospective clinical
study was conducted at seven study sites in
Turkey. Patients who underwent bilateral
cataract removal and implantation of a
diffractive, acrylic, hydrophobic, multifocal
IOL (Acriva UD Reviol MFB 625; VSY
Biotechnology, Istanbul, Turkey) were
included. The uncorrected and best corrected
distance visual acuities (UCDVA and BCDVA),
uncorrected and best corrected intermediate
visual acuities (UCIVA and BCIVA), and
uncorrected and best corrected near visual
acuities (UCNVA and BCNVA) were measured
preoperatively and at postoperative 1, 6, and
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12 months. Distance and near visual acuity
scores (VAS) contrast sensitivities were
measured at these time points. Quality of life
was evaluated by visual function-14 (VF-14)
questionnaire.
Results: Two hundred eyes of 100 patients were
included. Monocular and binocular visual
acuities at all distances showed improvement
at postoperative 12 months compared to
preoperative measurements (P\0.001).
Monocular and binocular UCIVA and
binocular BCIVA at postoperative 12 months
were significantly improved compared to
measurements at 1 month (P\0.001).
Binocular contrast sensitivity at distance
showed significant improvement from
postoperative 1 month to postoperative
12 months, except for 3 cycles per degree (cpd;
without glare) and 18 cpd (with glare). VAS
improved from 75.96 at postoperative 1 month
to 76.85 at postoperative 12 months. VF-14
score was 98.2 ± 4.6.
Conclusion: The Acriva UD Reviol MFB 625
appears to provide a good level of distance and
near visual acuity, quality of life, and patient
satisfaction. Further studies with longer follow-
up will provide valuable insight into the long-
term stability of these visual outcomes.
Keywords: Contrast sensitivity; Intraocular
lens; Visual acuity
INTRODUCTION
Monofocal intraocular lenses (IOLs) are
traditionally used to replace the opacified
natural lens that is removed during cataract
surgery. Limitations of such IOLs, primarily a
limited depth of focus providing clear vision
either at distance or near, and dependence on
reading spectacles for clear vision at all other
viewing distances, have long been recognized
[1, 2].
Refractive multifocal IOLs were developed to
provide clear, spectacle-free vision over a wider
range of distances. These IOLs distribute the
incoming light to hit multiple focal points on
the lens, consequently, creating multiple
simultaneous retinal images. A disadvantage is
that only one of these images is in focus at any
given time. All other out-of-focus images may
be detected as disturbances, including glare,
halos, and poor contrast sensitivity [3]. In
addition, some existing multifocal IOL designs
distribute more light to the distance focus,
compromising near visual acuity [4, 5].
In response to these limitations, diffractive
multifocal IOL models have been developed.
Unlike refractive multifocal IOLs, which have a
series of focal zones for incoming light,
diffractive IOLs have just two separate focal
points: one for distance and one for near vision.
Because of this design, diffractive multifocal
IOLs may provide clear, spectacle-free distance
and near vision, while avoiding the poor visual
quality that typically arises from multiple foci
[1].
We conducted this study to assess objective
and subjective visual outcomes of patients
implanted with the Acriva UD Reviol MFB 625
(VSY Biotechnology, Istanbul, Turkey), a
hydrophobic, diffractive multifocal IOL.
METHODS
This multicenter, prospective clinical study
involved patients scheduled to undergo
cataract surgery between October 2010 and
July 2011 at seven study sites. The study was
conducted in accordance with the ethical
standards stated in the Declaration of Helsinki,
and all patients provided informed consents
22 Ophthalmol Ther (2015) 4:21–32
prior to the study. The study was approved by
the Ethics Committee of the coordinator center
which was Uludag University Medical Faculty,
Bursa, Turkey.
All patients underwent bilateral
phacoemulsification followed by implantation
of a foldable, hydrophobic acrylic diffractive
multifocal IOL (Acriva UD Reviol MFB 625; VSY
Biotechnology, Istanbul, Turkey).
Acriva UD Reviol MFB 625 (Fig. 1) has active
diffractive multifocal optic and is fully pupil-
independent with 29 diffractive rings located in
the anterior surface. The IOL is designed as
single piece and aspheric and has UV
photoprotection and square edge. Its optic size
is 6.0 mm and total diameter is 12.5 mm. Its
haptic design is balance modified C. The near
add at the IOL plane is ?3.75 D and the light
distribution is 60% for distance and 40%
between foci. Acriva UD Reviol MFB 625
distributes the light between far to near focus.
With 2.0 mm pupil size, 72.1% of light is
transmitted to far focus and 27.9% of light is
distributed to near focus. With a pupil size of
5.0 mm, 60% of light is directed to far focus and
40% of light is transferred to near focus.
Cataract surgery on the second eye was
performed 1 week after the first eye. Patients
aged between 40 and 75 years, with bilateral
cataract and who volunteered to return to the
clinic for repeated assessments of visual
outcomes, were included. Exclusion criteria
included patients with unilateral
pseudophakia, diabetes mellitus, macular
disease, pupillary dysfunction, corneal
astigmatism exceeding 0.75 diopters, those
with occupations requiring high contrast
sensitivity (e.g., surgeon or pilot), or those
with occupations with increased risk of
dysphotopsia (e.g., night time drivers).
Preoperatively, spherical and cylindrical
refractive error, keratometry values, intraocular
pressure (IOP), and pupil diameter under
normal light conditions were measured and
recorded. Optical coherence tomography was
performed and pachymetry measurements were
documented. Distance visual acuity was
measured and recorded using the Early
Treatment Diabetic Retinopathy Study (ETDRS)
scale. Near (from 35 cm) and intermediate
visual acuities (from 60 cm) were measured
with the Jaeger card. Monocular and binocular
uncorrected and corrected visual acuities at all
three distances were assessed.
The study was conducted across seven
centers. All centers adopted the same
standardized surgical approach and surgical
steps for cataract removal and IOL
implantation. Before surgery, cataract density
was measured based on the Emery and Little
classification. Axial length was determined with
immersion biometry (Bioline, Opticon
Groningen, Netherlands). The SRK-II formula
was used to determine the IOL power to reach
the target refraction of emmetropia.
Phacoemulsification surgery was performed
under topical anesthesia, through a 2.2 mm
temporal clear corneal incision. Viscoelastic
material was inserted into the anterior
chamber and a central capsulorhexis, 5 mm in
diameter, was created. The nucleus material wasFig. 1 Acriva UD Reviol MFB 625
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fragmented, aspirated, and irrigated. The Acriva
UD Reviol MFB 625 multifocal IOL was inserted
through the incision, using its injector system.
After ensuring the correct positioning of the
lens in the capsular bag, viscoelastic material
was removed from the anterior chamber and
back surface of the IOL 0.1 mL of cefuroxime
was administered into the anterior chamber.
We measured the uncorrected and best
corrected distance visual acuities (UCDVA and
BCDVA), uncorrected and best corrected
intermediate visual acuities (UCIVA and
BCIVA), and uncorrected and best corrected
near visual acuities (UCNVA and BCNVA) of
patients preoperatively and at postoperative 1,
6, and 12 months. Distance contrast sensitivity
at four different spatial frequencies (3, 6, 12,
and 18 cycles per degree; with and without
glare) was also measured at these time points
(using CSV 1000 HGT; Vector Vision, Ohio,
USA). Near contrast sensitivity was assessed via
Colenbrander mixed contrast reading cards
[visual acuity score (VAS); VAS score ranges
from 35 to 105]. Each line included five letters
and one point was added for every letter read
correctly.
Quality of life was evaluated by visual
function-14 (VF-14) questionnaire, in which
scores ranged from 0 to 100. A score of 0–9
reflected ‘very severe impairment’, 10–29
reflected ‘severe impairment’, 30–74 reflected
‘moderate impairment’, 75–92 reflected ‘mild
impairment’, ‘93–98’ reflected ‘slight
impairment’, and 99–100 reflected ‘no visual
impairment’. A self-completion questionnaire
assessing patient satisfaction with 12-month
near, intermediate and distance visual acuities
during the day and at nighttime was also
completed. A scale of 1–4 was used, in which a
score of 1 indicates ‘very high satisfaction’, 2
reflects ‘good satisfaction’, 3 indicates
‘moderate satisfaction’, and 4 indicates ‘poor
satisfaction’. Patients were also asked to state if
they had any additional general complaints and
photic phenomena such as halo and glare.
Additional evaluations performed during
follow-up visits included measurement of IOP,
refractive and keratometry values, central
corneal thickness measurements by
pachymeter, and slit lamp examination.
Statistical Analysis
We performed statistical analysis using the
SPSS 15.0 program (IBM Corporation,
Armonk, NY, USA). Descriptive statistics are
presented as numbers and percentages for
categorical variables, and mean, standard
deviation, median, minimum and maximum
values for numerical variables. Multiple
comparisons for dependent groups for
numerical variables without normal
distribution were performed with Friedman
test; comparisons of two dependent samples
without normal distribution were performed
with Wilcoxon signed-rank test. Wilcoxon
signed-rank test with Bonferroni correction
was used for post hoc comparisons. For
categorical variables, comparison of two
dependent samples was made using McNemar
test. A P value less than 0.05 was considered
statistically significant.
RESULTS
Two hundred eyes of 100 patients (53% male),
with a mean age of 62.60 ± 9.32 years, were
included in this study. All patients were
followed up for a period of at least 12 months.
Of the patients, 97% had visual loss in both
eyes. The hardness of the cataractous lens was
2.7 ± 0.8, the axial length was 23.2 ± 0.9 mm,
and the power of the IOL implanted was
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21.3 ± 2.4 diopters. The visual characteristics of
the patients at baseline and at 1, 6, and
12 months of surgery, are presented in Table 1.
The percentages of the patients within 0.5 D of
manifest spherical equivalent and 0.5 D of
cylinder are presented in Table 2.
Monocular and binocular visual acuities at all
distances showed improvement at postoperative
12 months compared to preoperative
measurements (P\0.001, for all). The
binocular UCDVA was 0.84 ± 0.21 dec, UCIVA
was J 1.14 ± 0.39 dec, and UCNVA was J
1.04 ± 0.19 at postoperative 12 months.
Monocular and binocular visual acuities
recorded preoperatively and at 1, 6, and
12 months of surgery are presented in Table 3.
Distribution of monocular and binocular visual
acuities based on Snellen chart according to age
groups is presented in Table 4.
Binocular contrast sensitivity results with
and without glare at 3, 6, 12, and 18 cycles
per degree (cpd) at 1, 6, and 12 months of
surgery are presented in Table 5. Normal
reading levels of contrast sensitivity were
defined as 0–8 cpd.
Binocular distance contrast sensitivity values
(with and without glare) for each spatial
frequency showed significant improvement at
postoperative 12 months compared with
postoperative 1 month, except for 3 cpd
(without glare) and 18 cpd (with glare).
There was no significant change in
monocular and binocular near contrast
sensitivity (VAS) values with time. Monocular
Table 1 Visual characteristics of the patients at baseline and at 1, 6, and 12 months of surgery
Visual characteristics
(n5 78)
Preoperative Postoperative
1 month
Postoperative
6 months
Postoperative
12 months
P
Spherical refraction – -0.24 ± 0.59 -0.16 ± 0.62 -0.18 ± 0.64 0.163
Cylindrical refraction -0.35 ± 0.52b,c,d -0.64 ± 0.50a -0.63 ± 0.45a -0.61 ± 0.51a \0.001
C1 43.38 ± 1.30b,c 43.19 ± 1.26a 42.89 ± 2.80a 43.23 ± 1.29 0.005
C2 43.81 ± 1.49 43.89 ± 1.37c 43.67 ± 2.79b 43.89 ± 1.36 0.028
Intraocular pressure (mmHg) 14.92 ± 2.29 14.44 ± 2.19 14.38 ± 2.29 13.92 ± 2.17 0.065
Central corneal thickness (lm) 552.56 ± 32.9b,c 565.9 ± 76.82a,c,d 551.19 ± 72.87a,b,d 549.7 ± 46.65b,c \0.001
Values are presented as mean ± standard deviation
C1 horizontal axis of the cornea, C2 vertical axis of the cornea
a Different from the preoperative value
b Different from postoperative 1 month
c Different from postoperative 6 months
d Different from postoperative 12 months
Table 2 Percentages of the patients within 0.5 D of manifest spherical equivalent and 0.5 D of cylinder
n5 78 Preoperative Postoperative
1 month
Postoperative
6 months
Postoperative
12 months
(20.5 D)–(0.5 D) (20.5 D)–(0.5 D) (20.5 D)–(0.5 D) (20.5 D)–(0.5 D)
Spherical refraction, n (%) – 54 (69.2) 56 (71.8) 51 (65.4)
Cylindrical refraction, n (%) 56 (71.8) 41 (52.6) 40 (51.3) 36 (46.2)
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and binocular near contrast sensitivity values at
postoperative 1, 6, and 12 months are shown in
Fig. 2.
Quality of life assessed at postoperative
12 months was very high, as reflected by a
mean VF-14 score of 98.2 ± 4.6. Only five
(2.3%) patients reported halo and glare at
postoperative 12 months. Patient satisfaction
for distance, intermediate and near vision at
postoperative 1, 6, and 12 months evaluated by
the self-reporting questionnaire is presented in
Table 6.
None of the patients developed posterior
synechia and capsular fibrosis during the study
period. Posterior capsular opacification (PCO)
developed in six eyes at 6 months, and one eye
required neodymium-doped yttrium aluminum
garnet (Nd:YAG) capsulotomy; PCO occurred in
29 eyes at 12 months and 18 of them required
Nd:YAG capsulotomy.
Table 3 Monocular and binocular visual acuities recorded preoperatively and at 1, 6, and 12 months of surgery
Preoperative Postoperative
1 month
Postoperative
6 months
Postoperative
12 months
P
UCDVA
Monocular (dec) 0.12 ± 0.27b,c,d 0.75 ± 0.21a 0.75 ± 0.22a 0.76 ± 0.21a \0.001
Binocular (dec) 0.38 ± 0.19b,c,d 0.82 ± 0.21a 0.84 ± 0.21a 0.84 ± 0.21a \0.001
BCDVA
Monocular (dec) 0.45 ± 0.42b,c,d 0.90 ± 0.13a,c 0.99 ± 0.53a,b 0.93 ± 0.12a \0.001
Binocular (dec) 0.59 ± 0.21b,c,d 0.94 ± 0.16a 0.97 ± 0.12a 0.97 ± 0.13a \0.001
UCNVA
Monocular (Jaeger) 4.48 ± 1.31b,c,d 1.28 ± 0.59a 1.18 ± 0.37a 1.15 ± 0.37a \0.001
Binocular (Jaeger) 4.16 ± 1.44b,c,d 1.13 ± 0.44a 1.09 ± 0.29a 1.04 ± 0.19a \0.001
BCNVA
Monocular (Jaeger) 2.60 ± 1.41b,c,d 1.12 ± 0.29a 1.07 ± 0.21a 1.06 ± 0.23a \0.001
Binocular (Jaeger) 2.25 ± 1.29b,c,d 1.04 ± 0.25a 1.03 ± 0.16a 1.01 ± 0.11a \0.001
UCIVA
Monocular (Jaeger) 4.69 ± 1.27b,c,d 1.68 ± 0.90a,d 1.54 ± 0.80a 1.38 ± 0.63a,b \0.001
Binocular (Jaeger) 4.44 ± 1.20b,c,d 1.38 ± 0.71a,d 1.35 ± 0.60a,d 1.14 ± 0.39a \0.001
BCIVA
Monocular (Jaeger) 3.03 ± 1.49b,c,d 1.31 ± 0.56a,d 1.24 ± 0.55a 1.17 ± 0.42a,b \0.001
Binocular (Jaeger) 2.77 ± 1.44b,c,d 1.18 ± 0.51a 1.17 ± 0.44a 1.06 ± 0.25a,b,c \0.001
Values are presented as mean ± standard deviation
BCDVA best corrected distance visual acuities, BCIVA best corrected intermediate visual acuities, BCNVA best corrected
near visual acuities, UCDVA uncorrected distance visual acuities, UCIVA uncorrected intermediate visual acuities, UCNVA
uncorrected near visual acuities
a Different from the preoperative value
b Different from postoperative 1 month
c Different from postoperative 6 months
d Different from postoperative 12 months
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DISCUSSION
The wide range of focus and depth of focus
provided by multifocal IOLs can be
compromised by the limited visual quality
often experienced by patients implanted with
these IOLs [1]. Diffractive multifocal IOLs, such
as the Acriva UD Reviol MFB 625, create 2 focal
points, to assist smooth transition when
viewing images at different focal zones. This
aims to reduce the photic phenomena like halos
and glare. It was reported by Elzawawi et al. [6]
that near and distance visual acuities achieved
with a diffractive multifocal IOL were found
Table 4 Distribution of monocular and binocular visual acuities based on Snellen chart according to age groups
20/25 and better
All patients n (%) Age groups
<50 years n (%) 50–65 years n (%) >65 years n (%)
Binocular
UCDVA 56 (71.8) 7 (70.0) 27 (84.4) 22 (61.1)
UCNVA 75 (96.2) 10 (100.0) 32 (100.0) 33 (91.7)
UCIVA 68 (87.2) 9 (90.0) 29 (90.6) 30 (83.3)
Monocular
UCDVA 50 (64.1) 7 (70.0) 23 (71.9) 20 (55.6)
UCNVA 64 (82.1) 9 (90.0) 28 (87.5) 27 (75.0)
UCIVA 52 (66.7) 8 (80.0) 23 (71.9) 21 (58.3)
UCDVA uncorrected distance visual acuities, UCIVA uncorrected intermediate visual acuities, UCNVA uncorrected near
visual acuities
Table 5 Results of binocular contrast sensitivity with and without glare at 3, 6, 12, and 18 cpd at 1, 6, and 12 months of
surgery
Spatial frequency (cpd) Postoperative 1 month Postoperative 6 months Postoperative 12 months P
3 (without glare) 1.52 ± 0.19 1.54 ± 0.24 1.54 ± 0.23 0.371
3 (with glare) 1.40 ± 0.23b,c 1.45 ± 0.25a 1.46 ± 0.21a 0.008
6 (without glare) 1.62 ± 0.23b,c 1.68 ± 0.24a 1.69 ± 0.23a \0.001
6 (with glare) 1.50 ± 0.26b,c 1.57 ± 0.25a 1.59 ± 0.26a \0.001
12 (without glare) 1.22 ± 0.26b,c 1.30 ± 0.24a 1.33 ± 0.25a \0.001
12 (with glare) 1.14 ± 0.27b,c 1.21 ± 0.27a 1.25 ± 0.28a 0.005
18 cpd (without glare) 0.76 ± 0.28b,c 0.82 ± 0.31a,c 0.88 ± 0.33a,b \0.001
18 cpd (with glare) 0.68 ± 0.31 0.74 ± 0.31 0.77 ± 0.33 0.051
Values are presented as mean ± standard deviation
cpd cycles per degree
a Different from postoperative 1 month
b Different from postoperative 6 months
c Different from postoperative 12 months
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better compared to those achieved with a
refractive multifocal IOL.
The findings of the current study suggest
that the Acriva UD Reviol MFB 625 IOL
improves patient visual acuity at all distances,
near and distance contrast sensitivity, quality of
life and patient satisfaction by 12 months after
implantation.
The Acriva UD Reviol MFB 625 has a near
addition of ?3.75 D with a light distribution of
60% for distance focus and 40% for near focus.
The current study findings showed that patients
implanted with this IOL experienced a gradual
improvement in mean monocular and
binocular visual acuities at each successive
visit. The level of visual acuity achieved in the
current study is noticeably better than that
reported by similar studies involving refractive
multifocal IOLs. For example, in a study by
Steinert et al. [4] 80.0% of patients achieved a
UCNVA above J3 and in the current study,
82.8% of the patients achieved a UCNVA of J1
or better by the twelfth postoperative month. In
a study by Can et al. [7], in which visual
outcomes with two diffractive multifocal IOLs
(the Acriva UD Reviol MFM 611 and Acri Lisa
366D) were compared, distance and near visual
acuities were found to be similar with both
IOLs. Intermediate vision, however, was better
with the Acriva UD Reviol MFM 611 IOL. There
is a difference between two multifocal IOL
model Reviol MFB 625 and Reviol MFM 611 in
terms of haptic design. Reviol MFB 625 is
designed by Balance C haptic structure which
has a hole between two arms both front and
back haptic. Balance C design is known to have
more resistance to possible pressure from
capsular bag. Acriva UD Reviol MFM 611 is
plate design which is suitable for micro-incision
cataract surgery.
The defocus curve was not investigated in
the present study. However, the defocus curve
of Acriva Reviol BB MF 613 and BB MFM 611
was investigated and compared with Acrysof
Restor SN6AD1 and SN6AD3 in Wang et al.’s [8]
study. A defocus curve was created with
different levels of defocus and no difference
was observed among the three groups at a
viewing distance range of 67 cm and beyond
in that study.
Contrast sensitivity measurements offer an
objective measure of quality of vision. The
present study did not have an adequate
control group. For this reason, we compared
the results with previous study results. In Can
et al.’s [7] study, the clinical results of 2
diffractive multifocal IOLs, Acriva Reviol MFM
611 and Acri.Lisa 366D, were compared and
stated that although differences in mesopic
contrast sensitivity with glare and without
glare between the 2 IOLs were not statistically
significant, the results were better with the
Acriva Reviol MFM 611 IOL. Both distance and
near contrast sensitivity were assessed in a
multifocal versus monofocal IOL study by
Monte´s-Mico´ et al. [9]. Distance contrast
sensitivity was better with a monofocal than
multifocal IOL during the first 3 months after
surgery. However, contrast sensitivity
significantly improved, especially after the
third month, reaching the same level as that
Fig. 2 Results of monocular and binocular near contrast
sensitivity at postoperative 1, 6, and 12 months. Postop
postoperative, VAS visual acuity score
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Table 6 Patient satisfaction for distance, intermediate, and near vision at 1, 6, and 12 months of surgery
Postoperative 1 month Postoperative 6 months Postoperative 12 months P
Distance
Home
Monocular 1.71 ± 0.58c 1.63 ± 0.62c 1.46 ± 0.57a,b 0.002
Binocular 1.53 ± 0.55c 1.45 ± 0.53 1.36 ± 0.54a 0.022
Sunlight
Monocular 1.73 ± 0.60c 1.72 ± 0.63c 1.52 ± 0.56a,b 0.002
Binocular 1.55 ± 0.62 1.55 ± 0.55 1.48 ± 0.55 0.566
Night
Monocular 1.78 ± 0.63c 1.73 ± 0.57c 1.58 ± 0.55a,b 0.002
Binocular 1.61 ± 0.57 1.60 ± 0.54 1.55 ± 0.55 0.467
Near
Home
Monocular 1.59 ± 0.50c 1.52 ± 0.54c 1.38 ± 0.48a,b 0.001
Binocular 1.49 ± 0.50c 1.44 ± 0.50 1.34 ± 0.48a 0.016
Sunlight
Monocular 1.61 ± 0.53c 1.51 ± 0.54c 1.37 ± 0.49a,b \0.001
Binocular 1.47 ± 0.50c 1.44 ± 0.50c 1.31 ± 0.47a,b 0.008
Night
Monocular 1.64 ± 0.55c 1.58 ± 0.53c 1.39 ± 0.52a,b \0.001
Binocular 1.55 ± 0.57c 1.52 ± 0.55c 1.34 ± 0.50a,b 0.001
Intermediate
Home
Monocular 1.67 ± 0.54c 1.65 ± 0.52c 1.40 ± 0.52a,b \0.001
Binocular 1.60 ± 0.57c 1.49 ± 0.55 1.36 ± 0.54a 0.001
Sunlight
Monocular 1.74 ± 0.57c 1.61 ± 0.60c 1.47 ± 0.58a,b \0.001
Binocular 1.57 ± 0.52c 1.51 ± 0.60 1.38 ± 0.54a 0.006
Night
Monocular 1.77 ± 0.62c 1.71 ± 0.58c 1.46 ± 0.57a,b \0.001
Binocular 1.64 ± 0.61c 1.60 ± 0.61c 1.38 ± 0.54a,b \0.001
Values are presented as mean ± standard deviation
a Different from postoperative 1 month
b Different from postoperative 6 months
c Different from postoperative 12 months
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achieved with the monofocal IOL by
postoperative 6 months, at all spatial
frequencies.
A study by Akcay et al. [10] compared the
contrast sensitivity achieved with the
multifocal Acriva UD Reviol and monofocal
AcrySof IOLs. Findings showed no significant
difference in distance contrast sensitivity
between the two groups. At 12 and 18 cpd,
Akcay et al. [10] found better contrast
sensitivity values in those implanted with the
Acriva UD Reviol than those implanted with the
AcrySof IOL. The findings from the current
study showed that normal levels of contrast
sensitivity were observed throughout the
follow-up period. A steady improvement was
observed over the first twelve postoperative
months. This indicates that the Acriva UD
Reviol MFB 625 provides good light
transmission, which may be due to its
diffractive design. There was a high level of
patient satisfaction with visual outcomes; only
2.3% of the patients reporting glare and halos.
In the present study, contrast sensitivity values,
with and without glare, were all within the
normal limits during the follow-up period. In
many other studies including diffractive and
refractive multifocal IOLs, similar results were
reported [8, 11–13]. Further studies with longer
follow-up are required to determine the long-
term stability of these results.
The Acriva UD Reviol MFB 625 design has a
360 sharp square edge to minimize the risk of
PCO. Serious PCO that required ND: YAG
capsulotomy developed in 18 eyes. No other
postoperative complications were noted. Biber
et al. [14] compared the incidence of PCO and
Nd:YAG laser capsulotomy rates of 3 IOL types.
PCO and Nd:YAG laser capsulotomy rates in 3
AcrySof IOLs were as follows, respectively, in
ReSTOR SN60D3, 42.7% and 25.3%, in Natural
SN60AT, 28.0% and 17.3%, and in SN60WF,
14.7% and 4.0%. In another study with AcrySof
ReSTOR and ReZoom IOLs, PCO rates were 54%
[15]. Martiano and Cochener [16] performed
Nd:YAG laser posterior capsulotomy for PCO in
52% of high myopic eyes with multifocal IOLs.
The effect of Nd:YAG laser posterior
capsulotomy for PCO on refraction was
investigated by Vrijman et al. [17]. They
concluded that in most cases, Nd:YAG laser
capsulotomy in patients with multifocal IOL’s
did not change the refraction. In the present
study, no complications were observed after
Nd:YAG laser posterior capsulotomy and this
procedure did not change the refraction.
The current study was limited by the absence
of a comparative group implanted with a
refractive multifocal IOL. Such a group of
patients would have allowed a direct
comparison of visual outcomes with refractive
and diffractive multifocal IOLs. In doing so, the
findings may have revealed the impact of
different IOL designs on visual disturbances
and contrast sensitivity. Researchers will benefit
from additional studies of a similar design in
which visual quality outcomes with different
types of diffractive multifocal IOLs are assessed.
This will provide more conclusive evidence
about the contribution of IOL design to the
visual outcomes. Additional longer and larger
scale studies will also be helpful in determining
the validity of the current findings and assessing
if the outcomes achieved in the current study
persist in the long term.
CONCLUSION
Bilateral implantation of a diffractive multifocal
IOL appears to produce good 12-month visual
acuity and contrast sensitivity at all distances,
in addition to high levels of patient satisfaction
with visual quality.
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